Arrestin proteins mediate microbial cellular adaptation and fungal virulence
抑制蛋白介导微生物细胞适应和真菌毒力
基本信息
- 批准号:10612333
- 负责人:
- 金额:$ 20.13万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-04-21 至 2025-03-31
- 项目状态:未结题
- 来源:
- 关键词:Adaptor Signaling ProteinAntibodiesArrestinsBindingBiochemicalBiological AssayBiological ProcessCell Cycle ProgressionCell WallCell physiologyCellsCellular StressChemicalsCo-ImmunoprecipitationsCryptococcusCryptococcus neoformansCryptococcus neoformans infectionDataDiseaseEnvironmentEpitopesEukaryotaHomeostasisHumanImmuneImmune responseIn VitroIndividualInfectionKnowledgeLabelLaboratoriesMaintenanceMediatingMediatorModelingModificationMycosesNutrient availabilityPathogenesisPathogenicityPhenotypePhysiologicalProcessProtein FamilyProteinsProteomicsRegulationRoleSeriesSpecificityStressSystemUbiquitinUbiquitinationVariantVirulenceWestern Blottingantimicrobialbiological adaptation to stresscomparativeexperimental studyextracellularflexibilityhost-microbe interactionsin vivoloss of functionmicrobialmicrobial hostmicroorganismmutantnovelpathogenic funguspathogenic microbepharmacologicprotein degradationprotein functionresponsetranslational applicationsubiquitin ligaseubiquitin-protein ligase
项目摘要
Abstract
In order to effectively cause disease, microorganisms must continuously sense and respond to rapidly
changing environments. For microbial pathogens, these adaptive cellular processes include the ability to respond
to host-derived stresses. The robustness with which microorganisms regulate these adaptive responses largely
determines their ability to survive within the infected host.
In the experiments outlined in this proposal, we build upon recent and converging data from our laboratory
supporting the importance of protein ubiquitination in microbial host responses. Originally defined for directing
proteins for degradation, ubiquitination is increasingly recognized as a means of precise regulation of the
localization and function of many target proteins. In the human fungal pathogen Cryptococcus neoformans, we
have identified the Rsp5 ubiquitin ligase as a key mediator of stress response and virulence. Our preliminary
experiments have begun to define the specific aspects of the pathogenic process that require Rsp5 activity,
including cell wall homeostasis and cell cycle progression. Consistent with emerging models of ubiquitination in
diverse species, our experimental results suggest that Rsp5 is directed to its protein targets by adaptor proteins,
including the arrestin protein family. Our initial in vitro and in vivo experiments indicate that the virulence-
associated phenotypes of the C. neoformans rsp5 mutant are likely a composite of individual contribution of
altered target protein function. By further defining the microbial ubiquitin ligase / adaptor / target protein axis, we
will more deeply explore the mechanisms by which stress-induced cellular responses influence fungal infections.
摘要
为了有效地引起疾病,微生物必须不断地感知并迅速作出反应。
不断变化的环境对于微生物病原体,这些适应性细胞过程包括响应
宿主产生的压力微生物调节这些适应性反应的鲁棒性在很大程度上
决定了它们在受感染宿主体内的生存能力。
在这个建议中概述的实验中,我们建立在我们实验室最近的和融合的数据之上。
支持蛋白质泛素化在微生物宿主反应中的重要性。最初定义为指导
蛋白质降解,泛素化越来越被认为是一种精确调节蛋白质降解的手段。
许多靶蛋白的定位和功能。在人类真菌病原体新型隐球菌中,我们
已经鉴定了Rsp 5泛素连接酶作为应激反应和毒力的关键介质。我们的初步
实验已经开始确定需要Rsp 5活性的致病过程的特定方面,
包括细胞壁稳态和细胞周期进程。与新出现的泛素化模型一致,
不同的物种,我们的实验结果表明,Rsp 5是针对其蛋白质靶点的衔接蛋白,
包括抑制蛋白家族。我们最初的体外和体内实验表明,毒力-
相关表型的C.新生儿rsp 5突变体可能是个体贡献的复合物,
改变靶蛋白功能。通过进一步定义微生物泛素连接酶/接头/靶蛋白轴,我们
将更深入地探索应激诱导的细胞反应影响真菌感染的机制。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
ANDREW ALSPAUGH其他文献
ANDREW ALSPAUGH的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('ANDREW ALSPAUGH', 18)}}的其他基金
Coordinated responses to host-derived stresses in C. neoformans
新型隐球菌对宿主应激的协调反应
- 批准号:
10637411 - 财政年份:2023
- 资助金额:
$ 20.13万 - 项目类别:
Arrestin proteins mediate microbial cellular adaptation and fungal virulence
抑制蛋白介导微生物细胞适应和真菌毒力
- 批准号:
10369482 - 财政年份:2022
- 资助金额:
$ 20.13万 - 项目类别:
Coordinated Regulation of Virulence Genes in C. neoformans
新型隐球菌毒力基因的协调调控
- 批准号:
8859954 - 财政年份:2011
- 资助金额:
$ 20.13万 - 项目类别:
Coordinated Regulation of Virulence Genes in C. neoformans
新型隐球菌毒力基因的协调调控
- 批准号:
8493973 - 财政年份:2011
- 资助金额:
$ 20.13万 - 项目类别:
Coordinated Regulation of Virulence Genes in C. neoformans
新型隐球菌毒力基因的协调调控
- 批准号:
8668884 - 财政年份:2011
- 资助金额:
$ 20.13万 - 项目类别:
Coordinated Regulation of Virulence Genes in C. neoformans
新型隐球菌毒力基因的协调调控
- 批准号:
8068059 - 财政年份:2011
- 资助金额:
$ 20.13万 - 项目类别:
Coordinated Regulation of Virulence Genes in C. neoformans
新型隐球菌毒力基因的协调调控
- 批准号:
8292127 - 财政年份:2011
- 资助金额:
$ 20.13万 - 项目类别:
Coordinated Regulation of Virulence Genes in C. neoformans
新型隐球菌毒力基因的协调调控
- 批准号:
7809263 - 财政年份:2009
- 资助金额:
$ 20.13万 - 项目类别:
Coordinated Regulation of Virulence Genes in C. neoformans
新型隐球菌毒力基因的协调调控
- 批准号:
8080553 - 财政年份:2009
- 资助金额:
$ 20.13万 - 项目类别:
C. neoformans cAMP signaling and pathogenesis
C. 新型隐球菌 cAMP 信号传导和发病机制
- 批准号:
7245424 - 财政年份:2006
- 资助金额:
$ 20.13万 - 项目类别:
相似海外基金
University of Aberdeen and Vertebrate Antibodies Limited KTP 23_24 R1
阿伯丁大学和脊椎动物抗体有限公司 KTP 23_24 R1
- 批准号:
10073243 - 财政年份:2024
- 资助金额:
$ 20.13万 - 项目类别:
Knowledge Transfer Partnership
Role of Natural Antibodies and B1 cells in Fibroproliferative Lung Disease
天然抗体和 B1 细胞在纤维增生性肺病中的作用
- 批准号:
10752129 - 财政年份:2024
- 资助金额:
$ 20.13万 - 项目类别:
CAREER: Next-generation protease inhibitor discovery with chemically diversified antibodies
职业:利用化学多样化的抗体发现下一代蛋白酶抑制剂
- 批准号:
2339201 - 财政年份:2024
- 资助金额:
$ 20.13万 - 项目类别:
Continuing Grant
Isolation and characterisation of monoclonal antibodies for the treatment or prevention of antibiotic resistant Acinetobacter baumannii infections
用于治疗或预防抗生素耐药鲍曼不动杆菌感染的单克隆抗体的分离和表征
- 批准号:
MR/Y008693/1 - 财政年份:2024
- 资助金额:
$ 20.13万 - 项目类别:
Research Grant
Developing first-in-class aggregation-specific antibodies for a severe genetic neurological disease
开发针对严重遗传神经系统疾病的一流聚集特异性抗体
- 批准号:
10076445 - 财政年份:2023
- 资助金额:
$ 20.13万 - 项目类别:
Grant for R&D
Discovery of novel nodal antibodies in the central nervous system demyelinating diseases and elucidation of the mechanisms through an optic nerve demyelination model
发现中枢神经系统脱髓鞘疾病中的新型节点抗体并通过视神经脱髓鞘模型阐明其机制
- 批准号:
23K14783 - 财政年份:2023
- 资助金额:
$ 20.13万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the mechanisms controlling the physicochemical properties and functions of supercharged antibodies and development of their applications
阐明控制超电荷抗体的理化性质和功能的机制及其应用开发
- 批准号:
23KJ0394 - 财政年份:2023
- 资助金额:
$ 20.13万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Role of antibodies in hepatitis E virus infection
抗体在戊型肝炎病毒感染中的作用
- 批准号:
10639161 - 财政年份:2023
- 资助金额:
$ 20.13万 - 项目类别:
Defining the protective or pathologic role of antibodies in Post-Ebola Syndrome
定义抗体在埃博拉后综合症中的保护或病理作用
- 批准号:
10752441 - 财政年份:2023
- 资助金额:
$ 20.13万 - 项目类别:
Human CMV monoclonal antibodies as therapeutics to inhibit virus infection and dissemination
人 CMV 单克隆抗体作为抑制病毒感染和传播的治疗药物
- 批准号:
10867639 - 财政年份:2023
- 资助金额:
$ 20.13万 - 项目类别:














{{item.name}}会员




